deltatrials
Terminated PHASE2 Interventional 1-arm NCT01953965

Look at Way the Heart Functions in People With Pulmonary Hypertension (PH) Who Have Near Normal Right Ventricle (RV) Function and People With Pulmonary Hypertension Who Have Impaired RV Function. Using Imaging Studies PET Scan and Cardiac MRI.

11C-acetate/18Fluorodeoxyglucose-FDG PET/Cardiac MRI in Pulmonary Hypertension

Sponsor: Brigham and Women's Hospital

Updated 2 times since 2017 Last updated: Sep 26, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Due to lack of funding.

Listed as NCT01953965, this PHASE2 trial focuses on Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension and remains terminated or withdrawn. Sponsored by Brigham and Women's Hospital, it has been updated 2 times since 2026, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – present · 113 months · monthly snapshotTerminated

Change History

2 versions recorded
  1. Feb 2017 — Present [monthly]

    Terminated PHASE2

  2. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Brigham and Women's Hospital
  • University of Maryland
  • University of Pennsylvania
  • Yale University
Data source: Brigham and Women's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations